Seoung Woo Ryu
Research Subjects
Research Interests
Seoung Woo Ryu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Byeong Seob Oh
Korean Collection for Type Cultures, Biological Resource Center, Institute of Bioscience and Biotechnology, Jeongeup, Republic of Korea
1 shared publication - Eun Seo Heo
Korean Collection for Type Cultures, Biological Resource Center, Institute of Bioscience and Biotechnology, Jeongeup, Republic of Korea
1 shared publication - Jae-Ho Jeong
Chonnam National University Medical School
1 shared publication - Jeong Chan Moon
Research center for Endangered Species, National Institute of Ecology, Yeongyang 36531, Republic of Korea
1 shared publication - Jeong Eun Bak
Korean Collection for Type Cultures, Biological Resource Center, Institute of Bioscience and Biotechnology, Jeongeup, Republic of Korea
1 shared publication - Ju-Hoon Lee
Korean Collection for Type Cultures, Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology
1 shared publication
Latest Publications
- 12 December 2023
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (1) , 1-9
Anti-obesity activity of human gut microbiota Bacteroides stercoris KGMB02265
Obesity is a global health threat that causes various complications such as type 2 diabetes and nonalcoholic fatty liver disease. Gut microbiota is closely related to obesity. In particular, a higher Firmicutes to Bacteroidetes ratio has been reported as a biomarker of obesity, suggesting that the phylum Bacteroidetes may play a role in inhibiting obesity. Indeed, the genus Bacteroides was enriched in the healthy subjects based on metagenome analysis. In this study, we determined the effects of Bacteroides stercoris KGMB02265, a species belonging to the phylum Bacteroidetes, on obesity both in vitro and in vivo. The cell-free supernatant of B. stercoris KGMB02265 inhibited lipid accumulation in 3T3-L1 preadipocytes, in which the expression of adipogenic marker genes was repressed. In vivo study showed that the oral administration of B. stercoris KGMB02265 substantially reduced body weight and fat weight in high-fat diet induced obesity in mice. Furthermore, obese mice orally administered with B. stercoris KGMB02265 restored glucose sensitivity and reduced leptin and triglyceride levels. Taken together, our study reveals that B. stercoris KGMB02265 has anti-obesity activity and suggests that it may be a promising candidate for treating obesity.
- 12 December 2023
- Published by Springer Nature in Archives of Microbiology
- Vol. 206 (1) , 1-9
Anti-obesity activity of human gut microbiota Bacteroides stercoris KGMB02265
Obesity is a global health threat that causes various complications such as type 2 diabetes and nonalcoholic fatty liver disease. Gut microbiota is closely related to obesity. In particular, a higher Firmicutes to Bacteroidetes ratio has been reported as a biomarker of obesity, suggesting that the phylum Bacteroidetes may play a role in inhibiting obesity. Indeed, the genus Bacteroides was enriched in the healthy subjects based on metagenome analysis. In this study, we determined the effects of Bacteroides stercoris KGMB02265, a species belonging to the phylum Bacteroidetes, on obesity both in vitro and in vivo. The cell-free supernatant of B. stercoris KGMB02265 inhibited lipid accumulation in 3T3-L1 preadipocytes, in which the expression of adipogenic marker genes was repressed. In vivo study showed that the oral administration of B. stercoris KGMB02265 substantially reduced body weight and fat weight in high-fat diet induced obesity in mice. Furthermore, obese mice orally administered with B. stercoris KGMB02265 restored glucose sensitivity and reduced leptin and triglyceride levels. Taken together, our study reveals that B. stercoris KGMB02265 has anti-obesity activity and suggests that it may be a promising candidate for treating obesity.